Nephrocalcinosis is the buildup of calcium salts within the kidney tissue itself, distinct from kidney stones that sit in the collecting system or urinary tract. Calcium deposits form inside the tubules or surrounding tissue of the kidney, and the condition ranges from a microscopic finding on biopsy to something visible on routine imaging. It can show up in premature newborns on a loop diuretic, in adults with overactive parathyroid glands, or in people with rare inherited metabolic diseases. Because it often produces no symptoms on its own and because its imaging patterns are not always recognized, nephrocalcinosis is frequently described in the radiology literature as a “common but forgotten entity.”
Medullary Versus Cortical
The kidney has two main structural zones: the inner medulla and the outer cortex. The vast majority of nephrocalcinosis is medullary, meaning the calcium deposits concentrate in the inner portion of the kidney where urine becomes most concentrated. Medullary nephrocalcinosis accounts for roughly 95 percent of all cases and is associated with the metabolic and hormonal conditions described throughout this article.
Cortical nephrocalcinosis is much rarer and tends to follow a different set of insults. It typically results from severe damage to the outer kidney tissue, as occurs with cortical necrosis after hemorrhagic shock, severe infections, or toxin exposure. A case report described a young man who developed diffuse cortical calcification across both kidneys after acute kidney failure from traumatic hemorrhagic shock; serial imaging showed progressive shrinkage of the kidneys alongside speckled calcification confined to the cortex.1PubMed. Renal cortical nephrocalcinosis following acute renal failure due to polytrauma This pattern, where destroyed cortical tissue calcifies as it scars, is visually and clinically distinct from the medullary form. A pictorial review of both patterns on ultrasound and CT has emphasized the importance of distinguishing them, since the underlying causes and clinical significance differ substantially.2British Journal of Radiology. Radiological features of nephrocalcinosis, a common but forgotten entity
Why Calcium Ends Up in the Wrong Place
Several overlapping mechanisms push calcium out of solution and into the kidney tissue. The common thread is that something tips the balance between how much calcium (or oxalate, or phosphate) the kidney is handling and how well it can keep those substances dissolved. When the concentration of calcium salts in the tubular fluid exceeds what the local environment can hold in solution, crystals nucleate and deposit in or around the tubular cells.
The deposits themselves are usually calcium phosphate (hydroxyapatite) in medullary nephrocalcinosis or calcium oxalate in conditions where oxalate is the main driver. Uric acid and other crystal types play a lesser role.3PubMed. Biopathological crystallization: a general view about the mechanisms of renal stone formation Where exactly the crystals lodge depends on the condition. In most forms of medullary nephrocalcinosis, deposits accumulate in the interstitium around the loops of Henle and the collecting ducts, exactly where the kidney concentrates urine to its highest levels.
The Most Common Causes in Adults
Primary hyperparathyroidism is one of the leading metabolic drivers. When the parathyroid glands overproduce parathyroid hormone, calcium is pulled from bone into the bloodstream, filtered through the kidneys in excess, and deposited in the renal tissue. In a large study of patients with primary hyperparathyroidism, about 23 percent had renal calcifications, roughly split between kidney stones and nephrocalcinosis. Those with calcifications had significantly higher blood calcium, higher urinary calcium, and higher parathyroid hormone levels than those without.4The Journal of Clinical Endocrinology & Metabolism. Predictors of Renal Function and Calcifications in Primary Hyperparathyroidism: A Nested Case-Control Study A separate investigation of Asian-Indian patients with symptomatic primary hyperparathyroidism confirmed that the combination of high blood calcium and excessive urinary calcium drives both stones and nephrocalcinosis.5PubMed. Prevalence, risk factors and effect of curative parathyroidectomy on nephrocalcinosis in Asian-Indian patients with symptomatic primary hyperparathyroidism
Distal renal tubular acidosis is another classic cause, especially of medullary nephrocalcinosis. The kidney’s collecting ducts lose the ability to properly acidify urine, which creates a persistently alkaline environment in the tubules. Alkaline urine is a perfect setup for calcium phosphate crystals to precipitate. Inherited forms involve mutations in at least three distinct genes, and the clinical picture ranges from mild metabolic acidosis with incidental stone detection to severe failure to thrive with extensive nephrocalcinosis.6Journal of Nephrology. Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis This condition illustrates a general principle: nephrocalcinosis is not just about having too much calcium; it is equally about the chemical environment inside the kidney that determines whether calcium stays dissolved or drops out as crystals.
Sarcoidosis, an inflammatory disease that most often affects the lungs and lymph nodes, can also cause nephrocalcinosis through a less intuitive route. Granulomas produced by the disease convert vitamin D into its active form outside the normal feedback loop, leading to elevated calcium absorption from the gut and eventually hypercalcemia and excessive urinary calcium. Because sarcoidosis is not typically thought of as a kidney disease, the renal complications can be overlooked.7PubMed Central. Renal manifestations of sarcoidosis: from accurate diagnosis to specific treatment
Primary Hyperoxaluria and Kidney Failure Risk
Primary hyperoxaluria is a group of rare inherited metabolic disorders in which the liver overproduces oxalate, flooding the kidneys with a substance that readily crystallizes with calcium. Nephrocalcinosis is common in these patients and carries serious prognostic implications. In a study of patients with primary hyperoxaluria, nephrocalcinosis was found in about a third of the cohort, including roughly 40 percent of those with the most severe form (type 1). High urine oxalate was associated with increased risk of both nephrocalcinosis and stone formation. After statistical adjustment, patients who developed new nephrocalcinosis during follow-up had a fourfold higher risk of progressing to kidney failure compared to those without it.8PubMed Central. Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria This makes nephrocalcinosis not just a marker of disease severity but an independent warning sign in this population.
Nephrocalcinosis in Premature Infants
One of the most studied populations for nephrocalcinosis is premature babies in neonatal intensive care. These infants are vulnerable for several reasons: their immature kidneys handle calcium inefficiently, they often receive calcium-rich parenteral nutrition, and they are frequently treated with furosemide, a powerful loop diuretic that increases calcium excretion into the urine. Furosemide exposure stands out as the single strongest risk factor. In one study of preterm infants, cumulative furosemide doses above 10 milligrams per kilogram of body weight were associated with a dramatically higher risk of nephrocalcinosis, with even lower birth weight and higher urinary calcium concentrations adding independent risk.9PubMed. Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants
A more recent cohort study of very low birth weight infants confirmed the association with furosemide and also identified rapid postnatal growth as an independent risk factor.10PubMed Central. Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural course The good news is that nephrocalcinosis in preterm infants often resolves or improves after the offending medications are stopped and the kidneys mature. Still, neonatologists monitor for it routinely because persistent deposits in early life could theoretically affect long-term kidney function.
Drug-Induced Nephrocalcinosis Beyond the NICU
Furosemide is not the only medication linked to nephrocalcinosis. Oral sodium phosphate solutions, once widely used for bowel cleansing before colonoscopy, have been linked to acute nephrocalcinosis and kidney failure. A case series described five patients who developed diffuse calcium phosphate deposits in the kidney tubules after using these preparations; kidney biopsies showed widespread tubular injury packed with calcium phosphate crystals.11PubMed. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing This complication is considered rare but led to regulatory warnings and a shift toward safer bowel preparation alternatives in patients with risk factors like pre-existing kidney disease or dehydration.
Vitamin D supplementation in excessive doses, certain chemotherapy agents, and high-dose calcium carbonate antacids (the once-common “milk-alkali syndrome”) can also drive nephrocalcinosis, though these scenarios are less frequently encountered today thanks to better awareness and dosing guidelines. The genetic causes are even more numerous, spanning dozens of inherited conditions affecting renal tubular transport, vitamin D metabolism, or oxalate handling.12American Journal of Physiology-Renal Physiology. Genetic, pathophysiological, and clinical aspects of nephrocalcinosis
How It Connects to Kidney Stones
Nephrocalcinosis and kidney stones are related but not the same thing, and the boundary between them is blurrier than you might expect. The clearest link comes from research on Randall’s plaque, a layer of calcium phosphate that forms in the deep tissue of the renal papilla and can serve as an anchoring surface for kidney stones to grow. Biopsies of stone-forming patients have shown that these plaques begin as tiny spherical deposits within the basement membranes of the thin loops of Henle, some as small as 50 nanometers. At these earliest sites, the surrounding cells and tissue look entirely normal, meaning the process starts silently at a microscopic level.13The Journal of Clinical Investigation. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle
Follow-up work narrowed the location further, showing that plaque forms preferentially in the ascending thin limbs of the loop of Henle rather than the descending limbs. This finding supports a specific theory of plaque formation involving the local chemical environment created as fluid moves through that segment of the nephron.14PubMed Central. Randall’s plaque in stone formers originates in ascending thin limbs Once plaque erodes through to the surface of the papilla, it becomes exposed to the supersaturated urine in the collecting system, and a calcium oxalate stone can grow on top of it. In this way, the interstitial nephrocalcinosis that started deep in the tissue becomes the foundation for a stone that eventually causes symptoms. Not all nephrocalcinosis leads to stones, but in the common calcium-oxalate stone former, Randall’s plaque is the bridge between the two conditions.
How Nephrocalcinosis Is Detected
Most cases are discovered incidentally on imaging done for another reason, or through targeted screening when a metabolic condition is known. Ultrasound and CT are the main tools, and they have different strengths depending on the situation.
For medullary nephrocalcinosis, ultrasound is generally the better choice. A study comparing the two modalities in patients with hypoparathyroidism found that ultrasound detected more cases of mild to moderate nephrocalcinosis than CT, with ultrasound scoring higher in over 80 percent of discordant cases. The cumulative odds of a higher score on ultrasound compared to CT were nearly six to one.15PubMed Central. Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism Ultrasound’s advantages extend beyond sensitivity: it is cheaper, involves no radiation, and can be performed at the bedside, making it especially practical for monitoring children or patients who need repeated imaging.
CT has the edge in specificity and in detecting cortical nephrocalcinosis, which produces a more dramatic calcification pattern on cross-sectional imaging. CT is also better for ruling out other conditions that might mimic nephrocalcinosis on ultrasound, such as medullary sponge kidney. The two modalities are complementary rather than interchangeable. In practice, clinicians often start with ultrasound for screening and follow up with CT when the diagnosis is unclear or when cortical involvement is suspected.
Symptoms and When Nephrocalcinosis Causes Trouble
Mild to moderate nephrocalcinosis often causes no symptoms at all. It is found because a clinician was looking for it in the context of a metabolic workup, or because an ultrasound for something unrelated happened to show bright echoes in the renal medulla. When symptoms do develop, they typically reflect either the underlying metabolic cause (fatigue, muscle weakness, and excessive thirst from high blood calcium, for instance) or complications like recurrent kidney stones.
Severe or long-standing nephrocalcinosis can impair the kidney’s ability to concentrate urine, a condition that mimics nephrogenic diabetes insipidus. A case report illustrated this in a woman with a 16-year history of excessive urination and thirst, who was found to have bilateral nephrocalcinosis from distal renal tubular acidosis associated with Sjögren’s syndrome. Her kidneys had lost the ability to concentrate urine even in response to water deprivation or antidiuretic hormone.16PubMed. Acquired nephrogenic diabetes insipidus secondary to distal renal tubular acidosis and nephrocalcinosis associated with Sjögren’s syndrome This represents an advanced consequence: widespread calcium deposits physically disrupting the medullary architecture that the kidney depends on for concentrating urine.
Whether nephrocalcinosis itself accelerates kidney failure independently of its underlying cause remains debated. In patients with chronic kidney disease, one biopsy study found that while microscopic nephrocalcinosis was common, it was serum phosphorus rather than the calcification itself that predicted progression to kidney failure requiring dialysis.17PubMed. Microscopic nephrocalcinosis in chronic kidney disease patients The picture differs in primary hyperoxaluria, as discussed earlier, where new-onset nephrocalcinosis clearly predicts worse outcomes. The answer seems to depend heavily on the cause: in some conditions, nephrocalcinosis is a bystander marker; in others, it actively damages the kidney.
Treatment Targets the Cause, Not the Calcium
There is no procedure that removes calcium deposits already embedded in kidney tissue. Treatment is entirely about addressing the metabolic driver so that new deposits stop forming and existing ones stop growing. In primary hyperparathyroidism, surgical removal of the overactive gland corrects the hypercalcemia and hypercalciuria that fuel the process. In distal renal tubular acidosis, alkali supplementation (usually citrate or bicarbonate) corrects the acidosis and reduces urinary calcium excretion. In sarcoidosis, corticosteroids suppress the granulomatous inflammation that drives excess vitamin D activation.
Thiazide diuretics occupy a specific niche. Unlike furosemide, which increases calcium loss in the urine, thiazides reduce it by promoting calcium reabsorption in the kidney. In children with X-linked hypophosphatemia, a genetic condition treated with phosphate and vitamin D supplements that often causes nephrocalcinosis as a side effect, adding hydrochlorothiazide reduced urinary calcium and stabilized the degree of nephrocalcinosis over several years of follow-up. Before thiazide treatment, nephrocalcinosis scores worsened substantially; after starting the drug, they remained stable.18PubMed. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia
General measures like adequate hydration, moderate salt intake, and dietary adjustments to avoid excessive calcium or oxalate supplementation apply across most forms of nephrocalcinosis. Potassium citrate is widely used both to alkalinize urine in stone formers and to provide the citrate that acts as a natural crystal inhibitor. None of these reverse established calcification, but they can slow or halt progression, which is the realistic goal.
Medullary Sponge Kidney and Chronic Pain
Medullary sponge kidney is a congenital condition where the small collecting tubules near the tips of the renal papillae are abnormally dilated, creating tiny cysts. These dilated tubules are prone to stasis and crystal formation, and nephrocalcinosis is a frequent finding on imaging. The condition is often grouped alongside nephrocalcinosis in differential diagnosis discussions, though the two are not synonymous.
What makes medullary sponge kidney particularly challenging is its association with severe, life-altering chronic pain that often persists even when there is no stone obstructing the urinary tract. The pain seems to be independent of identifiable kidney stones in many patients, and its cause is poorly understood. Management focuses on stone prevention and symptomatic care, but these measures are frequently inadequate, and no controlled studies of pain management specific to this condition have been performed.19Current Opinion in Nephrology and Hypertension. Medullary sponge kidney and chronic pain: is there a role for renal denervation Renal denervation, a procedure that disrupts the pain-signaling nerves around the kidney, has been explored as a potential treatment in theory, but essentially no data exist for its use in medullary sponge kidney specifically. For patients living with this condition, the gap between the severity of their symptoms and the tools available to treat them remains a source of real frustration.